Healthcare
Live Price
Offline$56.71
-2.56% today
1Y Change
+3.35%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RadNet, Inc. (RDNT) is a Healthcare stock with a market cap of $4.45B and listed on NASDAQ. The stock last traded around $56.71 and up 3.4% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +11.5%, EPS growth of -754.5%, a dividend yield of 0.0%. What stands out right now is revenue +11.5%, EPS -754.5%, free cash flow +90.4% with operating margin 3.0% and ROIC 1.0%. Valuation is more restrained than many high-expectation growth names at price/sales 2.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RDNT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RDNT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RDNT Max Drawdown
-38.60%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RDNT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+11.5%
EPS Growth
-754.5%
Gross Margin
11.2%
Net Margin
-0.9%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.